BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3999223)

  • 1. Functional properties of natural killer cells in carcinoma of the prostate.
    Wirth M; Schmitz-Dräger BJ; Ackermann R
    J Urol; 1985 Jun; 133(6):973-8. PubMed ID: 3999223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
    Koba F; Akiyoshi T; Tsuji H
    J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate.
    Marumo K; Ikeuchi K; Baba S; Ueno M; Tazaki H
    Keio J Med; 1989 Mar; 38(1):27-35. PubMed ID: 2716216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity in patients with prostatic carcinoma and its in vivo boosting with bacillus Calmette-Guérin.
    Schwemmer B; Lehmer A; Hofmann R; Braun J
    Urol Int; 1984; 39(6):321-6. PubMed ID: 6523641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
    Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity in patients with urologic cancer.
    Ma CP; Yu DS; Yeh MY; Chang SY; Han SH
    Eur Urol; 1987; 13(6):397-400. PubMed ID: 3428323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinoma.
    Kimber I; Moore M; Howell A; Wilkinson MJ
    Cancer Immunol Immunother; 1983; 15(1):32-8. PubMed ID: 6553505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells.
    Fink PC; Klaproth C; Peter HH
    Infection; 1984; 12(5):322-7. PubMed ID: 6392103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.
    Koba F; Akiyoshi T; Arinaga S; Wada T; Tsuji H
    Jpn J Surg; 1987 Mar; 17(2):83-90. PubMed ID: 2957537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.
    Eremin O; Ashby J; Stephens JP
    Int J Cancer; 1978 Jan; 21(1):35-41. PubMed ID: 342425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and regional natural cytotoxicity in patients with head and neck cancer.
    Vinzenz K; Micksche M
    J Maxillofac Surg; 1986 Oct; 14(5):270-5. PubMed ID: 3464682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region.
    Vinzenz K; Micksche M
    J Oral Maxillofac Surg; 1987 Jan; 45(1):42-7. PubMed ID: 2432206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
    Kadoyama C; Kimura H; Yamaguchi Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.
    Carballido J; Alvarez-Mon M; Solovera OJ; Menéndez-Ondina L; Durántez A
    J Urol; 1990 Jan; 143(1):29-33. PubMed ID: 2294256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interferon alfa-2c on the kinetics of spontaneous cell-mediated cytotoxicity in urothelial carcinoma in vivo and in vitro.
    Grups JW; Stock T; Frohmüller HG
    Urol Res; 1988; 16(6):399-402. PubMed ID: 3232274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties.
    Boysen P; Gunnes G; Pende D; Valheim M; Storset AK
    Dev Comp Immunol; 2008; 32(7):773-83. PubMed ID: 18177938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.